Health Bulletin 28/December/2023 Roshni Dhar28 Dec 2023 4:16 PM ISTHere are the top health stories for the day:Delhi: CISF seizes medicines worth Rs 80 lakh at IGI airport, two heldTwo international passengers were...
Zydus Healthcare gets Rs 284.58 crore income tax demand notice Ruchika Sharma27 Dec 2023 3:29 PM ISTThe demand is determined due to "apparent mistakes while processing its return of income', it said.
Conduct bioequivalence study: CDSCO Panel tells Zydus Healthcare on Glycopyrrolate, Indacaterol Metered dose inhalation Dr. Divya Colin22 Dec 2023 6:00 PM ISTNew Delhi: Rejecting the clinical trial waiver proposal, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Zydus Healthcare Gets CDSCO panel Nod To Market Vilanterol, Glycopyrrolate FDC metered dose inhalation Dr. Divya Colin23 Nov 2023 6:00 PM ISTNew Delhi: The drug major Zydus Healthcare has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Conduct Phase III clinical trial: CDSCO to Zydus Healthcare over FDC Empagliflozin plus Sitagliptin Dr. Divya Colin12 Nov 2023 4:00 PM ISTNew Delhi: In response to the proposal presented by the drug major Zydus Healthcare, the Subject Expert Committee ( SEC) functional under the Central...
Zydus Healthcare gets CDSCO Panel nod to study Fluticasone Furoate, Glycopyrronium, Vilanterol FDC Dr. Divya Colin22 Oct 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved drug major Zydus...
OPPI names Anil Matai as Director General Ruchika Sharma17 Oct 2023 11:49 AM ISTAnil has functioned on the boards of Zydus Healthcare, Bayer Zydus Pharma, Novartis Healthcare and Biochem Pharmaceutical Industries.
Zydus Healthcare Gets CDSCO Panel Nod To Market Vilanterol, Glycopyrrolate, Fluticasone Metered Dose Inhaler Dr. Divya Colin13 Oct 2023 6:00 PM ISTNew Delhi: Pharmaceutical major, Zydus Healthcare has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
Zydus Healthcare gets CDSCO Panel Nod To Manufacture, Market Dydrogesterone Extended Release Tablet Dr. Divya Colin5 Oct 2023 6:00 PM ISTNew Delhi: The drug major Zydus Healthcare has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Zydus Healthcare Gets CDSCO Panel To Study Dydrogesterone Extended-release Tablets Dr. Divya Colin6 May 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined the drug major Zydus...
Include more Govt sites: CDSCO panel to Zydus Healthcare on clinical trial of Pulmonary disease drug Susmita Roy10 Dec 2022 3:57 PM ISTNew Delhi: Citing that more Govt. sites should be included, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
NPPA panel suggests retail price of Atorvastatin, Bempedoic acid FDC marketed by Zydus Healthcare Roshni Dhar29 Oct 2022 5:00 PM ISTThe National Pharmaceutical Pricing Authority (NPPA) Committee has suggested the retail price of each film coated tablet containing Atorvastatin...
